Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark F Lew

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Neurobiology of Aging|May 29, 2007
Complete ascertainment of Parkinson disease in the Swedish Twin RegistryKarin Wirdefeldt, Margaret Gatz, Stephanie L Bakaysa, et al.
Neuroepidemiology|April 5, 2012
Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registersAdina L Feldman, Anna L V Johansson, Margaret Gatz, et al.
Expert Review of Neurotherapeutics|November 5, 2016
Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspectiveStuart H Isaacson, Stanley Fisher, Fiona Gupta, et al.
Clinical Parkinsonism & Related Disorders|December 10, 2021
AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutionsMark F Lew, Robert A Hauser, Stuart H Isaacson, et al.
Biomarkers in Medicine|July 3, 2019
Oligomeric α-synuclein is increased in basal tears of Parkinson's patientsSarah F Hamm-Alvarez, Curtis T Okamoto, Srikanth R Janga, et al.
Parkinsonism & Related Disorders|May 13, 2015
Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trialsMark F Lew, John T Slevin, Rejko Krüger, et al.
Neurocase|February 4, 2026
A novel mutation in colony-stimulating factor 1 receptor (CSF1R) causing CSF1R-related disorder (CSF1R-RD)Anup N Sonti, Elizabeth Joe, Jillian V Berry, et al.
Journal of the Neurological Sciences|April 23, 2017
Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registryRichard M Trosch, Alberto J Espay, Daniel Truong, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2005
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled studyDaniel Truong, Drake D Duane, Joseph Jankovic, et al.
Clinical Neuropharmacology|October 27, 2009
Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effectsKelly E Lyons, Joseph H Friedman, Neal Hermanowicz, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Neurobiology of Aging|May 29, 2007
Complete ascertainment of Parkinson disease in the Swedish Twin RegistryKarin Wirdefeldt, Margaret Gatz, Stephanie L Bakaysa, et al.
Neuroepidemiology|April 5, 2012
Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registersAdina L Feldman, Anna L V Johansson, Margaret Gatz, et al.
Expert Review of Neurotherapeutics|November 5, 2016
Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspectiveStuart H Isaacson, Stanley Fisher, Fiona Gupta, et al.
Clinical Parkinsonism & Related Disorders|December 10, 2021
AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutionsMark F Lew, Robert A Hauser, Stuart H Isaacson, et al.
Biomarkers in Medicine|July 3, 2019
Oligomeric α-synuclein is increased in basal tears of Parkinson's patientsSarah F Hamm-Alvarez, Curtis T Okamoto, Srikanth R Janga, et al.
Parkinsonism & Related Disorders|May 13, 2015
Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trialsMark F Lew, John T Slevin, Rejko Krüger, et al.
Neurocase|February 4, 2026
A novel mutation in colony-stimulating factor 1 receptor (CSF1R) causing CSF1R-related disorder (CSF1R-RD)Anup N Sonti, Elizabeth Joe, Jillian V Berry, et al.
Journal of the Neurological Sciences|April 23, 2017
Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registryRichard M Trosch, Alberto J Espay, Daniel Truong, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2005
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled studyDaniel Truong, Drake D Duane, Joseph Jankovic, et al.
Clinical Neuropharmacology|October 27, 2009
Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effectsKelly E Lyons, Joseph H Friedman, Neal Hermanowicz, et al.
Pageof 5